Astragaloside IV downregulates the expression of miR−192 and thus exerted the therapeutic effect on DN, which might be associated with repression of excessive mesangial proliferation and renal fibrosis via the TGF-β1/Smad/miR-192 pathway. Here, TGFB1 is linked to liver dysplastic nodule.